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Abstract
Aims: The aim of this study was to characterize phenotypical properties, to
analyse whole genomes of novel Acinetobacter baumannii phages infecting
carbapenem-resistant Ac. baumannii (CRAB) and to evaluate their potential as
antimicrobial alternatives to control Ac. baumannii in clinical settings.
Methods and Results: The Ac. baumannii phages, Β/-R1215 and Β/-R2315,
were isolated from sewage samples. These phages were characterized by
transmission electron microscopy, host spectrum, the thermal/pH stability test,
the bacterial lysis assay and the whole genome analysis. Both phages lysed 21
of 45 CRAB hosts, and showed high stability at various pH (pH 4–10) and
temperature (25–60°C), and were strongly active against host bacteria in vitro.
The genomes of Β/-R1215 and Β/-R2315 are linear double-strands of DNA
with 44866 and 44846 bp respectively. These two genomes revealed high
similarity at the DNA level, but the organization and direction of open reading
frames were different.
Conclusions: The Ac. baumannii phages, Β/-R1215 and Β/-R2315, are novel
lytic phages lysing CRAB strains which were isolated from respiratory samples
of patients.
Significance and Impact of the Study: In vitro and in silico data showed that
these novel Ac. baumannii phages, Β/-R1215 and Β/-R2315, have potential as
antimicrobial alternatives to control CRAB in healthcare settings.
Introduction
Acinetobacter baumannii is an opportunistic pathogen
that has caused severe hospital-associated infections
worldwide (Dijkshoorn et al. 2007; Munoz-Price and
Weinstein 2008). In recent decades, the wide use of
broad-spectrum antibiotics has caused increased rates of
resistance in Ac. baumannii to most commercially avail-
able antibiotics (Dijkshoorn et al. 2007; Magiorakos et al.
2012). Carbapenem antibiotics are the last resort to treat
Gram-negative bacterial infections; however, Ac. bauman-
nii is even resistant to carbapenems including imipenem
and meropenem (Nordmann and Poirel 2002). These
resistances make treatment difficult in intensive care units
and have caused great medical concerns worldwide
(Nordmann and Poirel 2002; Higgins et al. 2010; Chung
et al. 2014); therefore, more effective treatment plans are
in demand. As a new alternative strategy to control
antibiotic-resistant bacterial infections, bacteriophage
therapy has recently been applied (Kutateladze and Ada-
mia 2010; Burrowes et al. 2011).
After the discovery of phages by Frederick Twort in
1915 and Felix d’Herelle in 1917, phage therapy had been
studied and used to treat bacterial infections all over the
world, particularly in the United States and in the Eastern
European countries of Georgia and Russia (Alisky et al.
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1998; Abedon et al. 2011). The 1940s marked the start of
an antibiotics era with extensive development and use of
antibiotics; this movement detracted interest from phage
therapy in the Western world (Sulakvelidze et al. 2001).
However, recently, with the increased prevalence of seri-
ous problems with antibiotic-resistant bacteria, there is a
renewed interest in phages as an alternative to antibiotics
for the control of bacterial infections in animals and
humans (Bruttin and Brussow 2005; O’Flaherty et al.
2009; Abedon et al. 2011). In 2006, phage agents were
approved as additives against food-borne pathogens in
the United States (Mahony et al. 2011). Therefore, we
expect that bacteriophages can be developed into excel-
lent biocontrol agents in the clinical setting as well.
Till date, complete genome sequences and characteri-
zation of approx. 20 Ac. baumannii phages have been
reported in the NCBI database (http://
www.ncbi.nlm.nih.gov/pubmed, Accessed: 10 October.
2015). Most of these phages belong to one of the three
families in the order Caudovirales—Myoviridae, Podoviri-
dae or Siphoviridae (Peng et al. 2014). These data, in
addition to physiological data, can be used to extend our
understanding about the features of Ac. baumannii
phages. However, only few physiological characterizations
of these phages have been reported. For the successful
applications of Ac. baumannii phages as alternative natu-
ral antimicrobials, discovery of novel phages and more
detailed studies on physiological and genetic aspects is
essential.
In this study, two novel Myoviridae lytic phages (phage
Β/-R1215 and Β/-R2315) multidrug-resistant organisms,
specifically carbapenem-resistant Ac. baumannii (CRAB)
strains were isolated and physiologically characterized.
Also, these phages compared with other Ac. baumannii
phages by whole genome sequence analysis. This informa-
tion will aid in the development of phage-based treat-
ments for the control of Ac. baumannii-associated clinical
infections in hospitals.
Materials and methods
Bacterial strains and characterization
A total of 45 CRAB strains were isolated from clinical
samples of patients from 2011 to 2014. These strains were
identified using the VITEK 32GN system (bioMerieux,
Marcy l’Etoile, France) and matrix-assisted laser desorp-
tion/ionization time-of-flight mass spectrometry (VITEK
MS; bioMerieux). An antimicrobial susceptibility test was
performed using the disk diffusion method and the
VITEK N132 system (bioMerieux), and the data were
analysed as per the Clinical and Laboratory Standards
Institute guidelines (Wikler and Clinical and Laboratory
Standards, I. 2010). Specifically, CRAB YMC11/12/R1215
and YMC11/12/R2315 isolates, which were isolated from
respiratory samples, were used as host bacteria for the
phages in this study.
Isolation and purification of phages
The two Ac. baumannii phages were isolated from a sew-
age sample and were purified by the double-layer agar
plate method (Kropinski et al. 2009). Briefly, sodium
chloride (1 mol l1, Merck) and polyethylene glycol
(PEG) 8000 (at a final concentration of 10%) (Sigma,
St. Louis, MO) were added to the sewage samples and
incubated at 4°C for 24 h. After centrifugation (8000 g
for 10 min at 4°C) (Himac CP100WX; Hitachi, Tokyo,
Japan), the supernatant was filtered using a 022 lm
membrane filter (Millipore Corporation, Bedford, MA).
Phages were pelleted by centrifugation at 12 000 g for
1 h at 4°C, and resuspended in sterilized sodium chlo-
ride-magnesium sulphate (SM) buffer (100 mmol l1
NaCl, 8 mmol l1 MgSO4, 2% gelatin, 50 mmol l
1
Tris-HCl, pH 75).
Spot tests were performed by spotting 10 ll of phage
solution onto bacteria lawns on a Luria–Bertoni (LB,
Difco) agar plate. After overnight incubation, clear zone
formations were checked.
To purify phages, the double-layer agar plate method
was used to collect single-plaque isolations, which were
harvested and suspended in 1 ml of SM buffer. These
steps were carried out at least three times in order to
select the phages. To concentrate the phages, host strains
(OD600 = 05) and 10 ll of purified phage solution were
added to 4 ml of LB medium and incubated at 37°C for
12 h with shaking. Culture samples were centrifuged at
12 000 g at 4°C for 10 min and filtered to remove cell
debris. Then, PEG 8000 was added to a final concentra-
tion of 10% and the phage solution was centrifuged at
12 000 g at 4°C for 10 min. Subsequently, the solution
was incubated at 4°C for 12 h. The samples were then
resuspended in 1 ml of SM buffer and the concentrated
phage solution was stored at 4°C. Plaque assays were per-
formed to determine the number of plaque-forming units
(PFUs) in the phage solutions using the double-layer
method.
Host range of phages
A host range test was performed with Ac. baumannii
phages on strains of bacteria that were isolated from
patients at the hospital: 45 CRAB, five carbapenem-sus-
ceptible Ac. baumannii, five Pseudomonas aeruginosa, five
Escherichia coli, five Bacillus subtilis and five Staphylococ-
cus aureus.
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The sensitivity of the phages to the collected clinical
strains was evaluated by the spot test and efficiency of
plating (EOP) using the double-layer agar plate method.
The EOP is presented as a ratio of the phage titre on the
host strain to the titre on other tested strains (Frampton
et al. 2014).
Transmission electron microscopy
Purified phages (approx. 1010 PFU ml1) were laid on a
carbon-coated copper grid and stained with 2% (w/v)
uranyl acetate for 15 s. Prepared phage samples were
viewed using a transmission electron microscope (JEOL
JEM-1011, Tokyo, Japan) at 80 kV.
pH stability and thermal stability test
pH stability of the phages (106 PFU ml1) was evaluated
at pH values ranging from pH 4 to 10 for 30 days at
4°C. The phage survival was measured at day 1, 3, 5 and
30. The titre of all samples was assayed by using the dou-
ble-layer agar plate method. The data were compared
with those of the control samples (106 PFU ml1, pH
75). To evaluate the thermostability, the phage suspen-
sions (106 PFU ml1) were incubated at 25, 40, 50, 60 or
70°C for 3, 6 or 9 h (15 time/temperature combinations).
These results were compared with the control titre (at
4°C, pH 75 for each time point), and all results were
expressed as the percentage of phage titre (PFU ml1).
Host cell lytic activity test
Acinetobacter baumannii YMC11/12/R1215 and YMC11/
12/R2315 culture strains (OD600 = 02) were infected
with phages at different multiplicity of infections (MOIs,
MOI = 01, 1, 10) at 37°C with continuous shaking. Each
sample was analysed for host cell lytic activity at 1 h
intervals (up to 6 h) by assessing changes in OD600
(spectrophotometer: Shimadzu-1601, Tokyo, Japan). An
uninfected culture was used as a control and this experi-
ment was conducted in triplicate.
DNA preparation and sequencing analysis of phages
Genomic DNA of phage Β/-R1215 and Β/-R2315 was
extracted using the phenol extraction method as previ-
ously described (Wilcox et al. 1996) and was sequenced
using a 454 GS Junior Genome analyser (454 Life
Sciences/Roche, Branford, CT). The sequencing reads
were assembled using Roche GS Assembler ver. 2.6
(Roche) and CLC Genomics Workbench 6.5 (CLCbio
USA, Cambridge, MA). The open reading frame (ORF)
prediction was carried out with NCBI ORF finder (http://
www.ncbi.nlm.nih.gov/projects/gorf/) and GENMARK.HMM
software (Besemer et al. 2001). Overall genome sequences
of the phages were compared with other phages using the
Blast2seq tool, and the similarity of the predicted ORFs
was determined using PSI-BLAST (http://www.ebi.ac.uk/
Tools/sss/fasta/). Putative protein functions of the ORFs
were assessed using BLASTP in the NCBI database and
InterProScan 5 on the EMBL-EBI Website (http://www.e
bi.ac.uk/Tools/pfa/iprscan5/). Putative tRNA-encoding
genes were analysed using tRNAscan-SE 1.21 (http://low
elab.ucsc.edu/tRNAscan-SE/). A map of the phage gen-
ome was presented using DNAPlotter (Carver et al.
2009), and genome organization with other phages was
compared using MAUVE software ver. 2.3.1 (http://dar
linglab.org/mauve/mauve.html).
Nucleotide sequence accession number
The complete genome sequences of Ac. baumannii phage
Β/-R1215 and Β/-R2315 are accessible in the GenBank
database under accession numbers KP861231 and
KP861229 respectively.
Results
Identification of bacteria
A total of 45 CRAB strains were isolated from patients at
a tertiary hospital in South Korea (Table 1). All strains
were used for the host range determination of Ac. bau-
mannii phages Β/-R1215 and Β/-R2315. Among them,
Ac. baumannii YMC11/12/R1215 and Ac. baumannii
YMC11/12/R2315 isolates which showed resistant to all
antibiotics, except colistin (Table S1) were used as host
bacteria for the preparation of the phages in this study.
Morphology and host range test
Transmission electron microscopy revealed that Β/-
R1215 and Β/-R2315 had a head length of approx. 52
and 53 nm in diameter and contractile tails of approx. 79
and 77 nm in length respectively. Therefore, it was deter-
mined that both phages belong to the family Myoviridae
(Fig. 1). Both Ac. baumannii phages formed clear plaques
on 21 of 45 CRAB strains, 1 of 5 carbapenem-susceptible
Ac. baumannii strains, and 1 of 5 Staph. aureus strains.
However, they did not lyse clinical strains of Ps. aerugi-
nosa, E. coli or B. subtilis (Table 1).
pH and thermal stability test
To investigate the stability of the phages on various envi-
ronmental conditions, we observed the survival rate of
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Ac. baumannii phages Β/-R1215 and Β/-R2315 at vari-
ous pHs and temperatures. In the pH stability test of
phages, phage Β/-R1215 exhibited broad stability of
>92% between pH 4–10, the entire range assessed, on
day 1, and maintained 64%, 96% and 59% stability at
pH 4, pH 75 and pH 10 at day 30 respectively (Fig. 2a).
Phage Β/-R2315 showed broad stability of >80% at pH
4–10 on day 1, and 22%, 92% and 49% stability at pH
4, pH 75 and pH 10 at day 30 respectively (Fig. 2b). In
the temperature stability test, both phages showed high
stability (>96%) at 25°C up to 9 h and maintained at
least 30% stability after 9 h at 60°C. However, little or
no lytic activities were detected at 70°C for either phage
(Fig. 3).
Host cell lytic activity test
To evaluate the effectiveness and efficiency of phage Β/-
R1215 and Β/-R2315 as antimicrobial agents, we carried
out the bacterial lysis test of the phages against host bac-
teria. The results showed that both phages inhibited the
host bacterial growth up to 6 h at all MOIs tested. Inter-
estingly, phage Β/-R1215 exhibited lytic activity at an
MOI of 01 that was as strong as it was at MOI 10
against host bacteria respectively (Fig. 4a,c). On the other
hand, inhibition of bacterial growth by phage Β/-R2315
was dependent on the MOI (Fig. 4b,d).
Whole genome analysis of Acinetobacter baumannii
phages
Genome sequencing of Ac. baumannii phages Β/-R1215
and Β/-R2315 generated 7089 and 4663 sequence cov-
erage for each genome using 454 junior sequencing.
Β/-R1215 contained linear double-stranded (ds) DNA
containing 44 866 bp and a G+C content of 375%.
The genome of Β/-R2315 contained linear ds DNA
with 44 846 bp and a G+C content of 376%. Both
phages consisted of 85 predicted putative ORFs and
there were no putative tRNA genes in either genome.
Most of the ORFs were annotated as hypothetical pro-
teins, and only 14 and 12 ORFs were predicted as
(a) (b)
Figure 1 Images from transmission electron
microscopy of Acinetobacter baumannii
phages Β/-R1215 (a) and Β/-R2315 (b). The
bar represents a length of 100 nm.
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Figure 2 The pH stability of phages Β/-R1215 (a) and Β/-R2315 (b).
Phages were incubated at various pHs (pH 4–10) for 30 days at 4°C,
and the results were calculated as the percentage of surviving
phages. The error bars denote the standard deviation of three repli-
cates. (■) 1 day; ( ) 3 days; ( ) 5 days and ( ) 30 days.
72 © 2016 The Authors. Journal of Applied Microbiology 121, 68--77 published by John Wiley & Sons Ltd on behalf of Society for Applied Microbiology.
Novel Acinetobacter baumannii phages J. Jeon et al.
putative functional proteins in the Β/-R1215 and Β/-
R2315 genomes respectively (Fig 5a). All predicted pro-
teins displayed similar amino acid sequences to proteins
from Acinetobacter phage Β/-C62, as assessed using the
BLASTp search on the GenBank database (Tables S2
and S3).
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Figure 3 The thermal stability kinetics of
Acinetobacter baumannii phages Β/-R1215
(a) and Β/-R2315 (b). The temperature
stability of the two phages is represented as a
percentage of the surviving phages at 25, 40,
50, 60 and 70°C after 9 h. The error bars
denote the standard deviation of three
replicates. (■) 3 h; ( ) 6 h and ( ) 9 h.
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Figure 4 The time course of cell lysis by Acinetobacter baumannii phages Β/-R1215 (a, c) and Β/-R2315 (b, d). Carbapenem-resistant Ac. bau-
mannii YMC11/12/R1215 and YMC11/12/R2315 were infected with phages Β/-R1215 or Β/-R2315 at multiplicity of infection (MOI) 01, 1 and
10 respectively. Optical density (OD) was measured at 600 nm. The error bars denote the standard deviation of three replicates. ( ) Control;
( ) MOI = 01; ( ) MOI = 1 and ( ) MOI = 10.
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Phages Β/-R1215 and Β/-R2315 shared a high
sequence similarity (>90%) with the Ac. baumannii phage
Β/-C62 (Genbank Acc. No. KJ817802) belonging to the
Myoviridae family. Also, both the genomes were similar to
those of the Ac. baumannii phage IME-AB2 (Genbank Acc.
No. JX976549) belonging to Myoviridae family (80% simi-
larity) and the Ac. baumannii phage AB1 (Genbank Acc.
No. HM368260) (57% similarity). The phages also had a
very similar genome size of approx. 43–45 kb (Fig. 5b).
The functional ORFs of phages Β/-R1215 and Β/-
R2315 were classified as phage morphogenesis and struc-
tural modules, DNA replication and metabolism modules,
and lysis modules (Fig. 5a). The detailed annotation infor-
mation for two phage genomes was listed in Tables S2 and
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Acinetobacter phage IME-AB2
Acinetobacter phage AB1
4000 6000 8000 10000 12000 14000 16000 18000 20000 22000 24000 26000 28000 30000 32000 34000 36000 38000 40000 42000 44000
2000 4000 6000 8000 10000 12000 14000 16000 18000 20000 22000 24000 26000 28000 30000 32000 34000 36000 38000 40000 42000 44000
2000 4000 6000 8000 10000 12000 14000 16000 18000 20000 22000 24000 26000 28000 30000 32000 34000 36000 38000 40000 42000 44000
2000 4000 6000 8000 10000 12000 14000 16000 18000 20000 22000 24000 26000 28000 30000 32000 34000 36000 38000 40000 42000
2000 4000 6000 8000 10000 12000 14000 16000 18000 20000 22000 24000 26000 28000 30000 32000 34000 36000 38000 40000 42000 44000
Bφ-R2315
Bφ-C62
IME-AB2
AB1
Figure 5 A circular map of the Acinetobacter baumannii phages B/–R1215 and B/–R2315 genomes prepared using DNAPlotter (a) and a gen-
ome comparison of Ac. baumannii phage B/–R1215, phage B/–R2315 and other Ac. baumannii phages (B/–C62, IME-AB2, AB1) are repre-
sented by MAUVE software at the nucleotide level (b). A genome map of the two Ac. baumannii phages illustrates putative open reading frames
(ORFs) along with the direction of transcription represented by arrows. Functional proteins, GC content and GC skew are depicted by different
colours (a). The connecting coloured lines show the similar DNA regions between predicted ORFs of phage genomes and white bars indicate
annotated genes and reverse strands shifted downward (b). Details of annotated genes of the phage B/–R1215 and phage B/–R2315 genomes
are listed in the supplemental material (Tables S2 and S3). ( ) Morphogenesis protein; ( ) DNA replication and metabolism protein; ( ) Lysis pro-
tein; ( ) Hypothetical protein; (■) GC content; ( ) GC skew+ and ( ) GC skew.
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S3. Most of the contents of the phage proteins associated
with morphogenesis, replication, and lysis were similar
between phage Β/-R1215 and Β/-R2315 genomes with
regard to protein sequence identity, but the ORF organiza-
tion and direction were different (Fig. 5b).
Discussion
Recently, Ac. baumannii strains have become problematic
nosocomial pathogens due to their resistance to most
available antibiotics (Perez et al. 2007). The phages have
been proposed as alternative agents to protect and treat
the infectious diseases caused by antibiotic-resistant
pathogens. (Tiwari et al. 2011; Saussereau and Debarbi-
eux 2012; Wittebole et al. 2014). The aim of this study
was to isolate and characterize phages that target CRAB
and evaluate their effectiveness as an antimicrobial agent
to fight these bacteria.
Herein, we collected 45 strains of Ac. baumannii that
were confirmed as carbapenem-resistant. All the 45
strains were multidrug-resistant Ac. baumannii and were
resistant to most of the antibiotics (including imipenem
and meropenem) used in the study (data not shown).
Until recently, approx. 20 Acinetobacter phages have
been isolated. Among them, only five Ac. baumannii
phages—phages IME-AB2 (Peng et al. 2014), Acibe1004
(Merabishvili et al. 2014), AP22 (Popova et al. 2012),
ZZ1 (Jin et al. 2012) and Abp53 (Lee et al. 2011)—be-
long to the family Myoviridae and have been character-
ized and/or sequenced. In this study, we isolated and
purified two novel Myoviral Ac. baumannii phages, Β/-
R1215 and Β/-R2315, infecting CRAB clinical isolates
from the sewage water at the hospital. These phages were
characterized and completely sequenced.
The host spectrum of the phages is one of the most
important features to be considered for further therapeu-
tic application. In this study, a total of 70 bacteria iso-
lated from patients, including both Gram-negative and
Gram-positive strains, were used in host spectrum stud-
ies; lysis efficacy of the phages was recorded as EOP using
the double-layer agar plate method. Overall, Ac. bauman-
nii phages Β/-R1215 and Β/-R2315 showed broad host
ranges (approx. 46%) on CRAB isolates. Interestingly,
although both phages exhibited a difference of level of
EOP on each bacteria strain, they had the same host
range on tested bacteria isolates including one of the car-
bapenem-sensitive Ac. baumannii and one of the
Staph. aureus strains, and they showed relatively high
EOPs on the lysed bacteria strain (Table 1).
The adsorption rate and one-step growth curve are the
parameters for determining the efficacy of infective
phages on host bacteria and their life cycle (Hyman and
Abedon 2009). Phage Β/-R1215 and Β/-R2315 exhibited
a rapid adsorption rate of >98% in 5 min (Fig. S1). A
one-step growth of these phages showed a latent period
of approx. 30 and 40 min, respectively, and a burst size
of approx. 43 and 78 PFU per infected cell, respectively,
on host bacteria at 60 min (Fig. S2). Phages Β/-R1215
and Β/-R2315 exhibited similar adsorption rates when
compared with Ac. baumannii phage AP22 (>99%,
5 min) belonging to Myoviridae. However, phages Β/-
R1215 and Β/-R2315 showed a relatively longer latent
period and smaller burst size than previously published
data from Ac. baumannii phages Abp53 (150 PFU cell1),
ZZ1 (200 PFU cell1) and AP22 (240 PFU cell1), also
belonging to Myoviridae.
The pH and temperature stability of the phages is con-
sidered to be an important factor for optimum activity of
the phage on host bacteria. The results suggest that phage
Β/-R1215 was relatively more stable than phage B/-
R2315, that is, phage Β/-R1215 maintained higher activity
at acidic pH ranges and high temperatures between 50 and
60°C for 9 h (Figs 2 and 3). In comparison with other
known Ac. baumannii phages, phage Β/-R1215 and Β/-
R2315 exhibited significantly higher stability at a broader
pH range than Ac. baumannii phage ZZ1, belonging to
Myoviridae. Our phages maintained significant stability at
high acidic (pH 4) and alkaline (pH 10) pHs up to
30 days (Fig. 3). Acinetobacter baumannii phages ZZ1 and
AB1 (Yang et al. 2010), belonging to Siphoviridae, have
shown high temperature stability during 1 h incubation at
50–60°C, and phage Β/-R1215 and Β/-R2315 showed rel-
atively high stability up to 9 h between the same tempera-
ture range (Fig. 3). These results suggest that our novel
phages are at least as stable in the various clinical environ-
ments as Ac. baumannii phage ZZ1 and phage AB1.
To assess the phages as a potential antimicrobial agent,
we performed the host cell lysis test against host bacteria
in vitro. OD600 of bacterial growth infected with phage
Β/-R1215 at all different MOIs did not increase up to
6 h. Phage B/-R2315 also inhibited host bacterial growth
(i.e. OD600) dose-dependently and showed the highest
lysis activity at an MOI of 10 (Fig. 4). Both Ac. bauman-
nii phage Β/-R1215 and B/-R2315 exhibited significant
inhibition efficacy of bacterial growth in LB culture.
As shown in Fig. 5, despite the high level of DNA
sequence similarity between phage Β/-R1215 and Β/-
R2315 genomes, there is a substantial divergence in gene
organization. The sequence similarity may be associated
with the similar morphologies and the same host ranges.
Also, the genes associated with lysogeny, such as repressor
and integrase genes, or virulence factors (Plunkett et al.
1999) were not identified in either of phage genomes
(Tables S2 and S3). Therefore, based on the in vitro and
in silico results, we determined that phage Β/-R1215 and
Β/-R2315 are lytic bacteriophages.
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By comparing the genome of other phages, phages Β/-
R1215 and Β/-R2315 genomes exhibited a high level of
DNA sequence similarity and similar genome size with
Ac. baumannii phage Β/-C62 (Myoviridae), IME-AB2
(Myoviridae) and AB1 (Siphoviridae), however, overall
genome organization between these phages differs. Phages
IME-AB2 and AB1 have a circular genome, while phages
Β/-R1215 and Β/-R2315 have a linear genome, and it
was confirmed as the PCR by using primers designed
(data not shown). The detailed genome analysis of the
phages provides us not only crucial molecular insight
into the differences between phages but also expansion of
our understanding of the genetic diversity within Acineto-
bacter phage genomics. Indeed, these analyses are essential
process as significant parameters to assess the safety of
the phages prior to their use as therapeutic agents in the
future.
Additionally, to visualize the phage proteins, purified
each phage sample was separated by on 12% sodium
dodecyl sulphate-polyacrylamide gel electrophoresis. The
proteomic patterns also were similar between phage Β/-
R1215 and Β/-R2315, containing three major bands (ap-
prox. 30, 16, and 10 kDa) (Fig. S3).
Here, we report in detail the characterization and com-
plete genome sequence of two novel Myoviral Ac. bau-
mannii phages Β/-R1215 and Β/-R2315 infecting CRAB
clinical strains. The in vitro characterization in silico anal-
ysis results obviously shows that novel Ac. baumannii
phages Β/-R1215 and Β/-R2315 have potential as
antimicrobial alternatives to control CRAB strains
becoming a serious threat to the hospital settings.
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